KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Evolent Health (EVH) over the last 10 years, with Q3 2025 value amounting to $16.5 million.

  • Evolent Health's Interest Expenses rose 17412.65% to $16.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.2 million, marking a year-over-year increase of 4940.81%. This contributed to the annual value of $24.7 million for FY2024, which is 5439.17% down from last year.
  • Evolent Health's Interest Expenses amounted to $16.5 million in Q3 2025, which was up 17412.65% from $11.6 million recorded in Q2 2025.
  • Evolent Health's Interest Expenses' 5-year high stood at $16.5 million during Q3 2025, with a 5-year trough of $2.1 million in Q2 2022.
  • Over the past 5 years, Evolent Health's median Interest Expenses value was $6.4 million (recorded in 2022), while the average stood at $8.3 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 6576.35% in 2022, then surged by 57309.12% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Interest Expenses stood at $6.4 million in 2021, then fell by 0.28% to $6.4 million in 2022, then surged by 90.36% to $12.2 million in 2023, then crashed by 45.09% to $6.7 million in 2024, then surged by 145.16% to $16.5 million in 2025.
  • Its Interest Expenses was $16.5 million in Q3 2025, compared to $11.6 million in Q2 2025 and $10.4 million in Q1 2025.